Company profile
Axis Bioservices Limited
Axis Bio | Discovery Services
Axis Bio is a preclinical contract research organisation with specialist capabilities in oncology, inflammation and respiratory diseases.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts due
Accounts DueNext accounts due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Accounts With Accounts Type Total Exemption Full
Accounts PDF pendingAA | Transaction MzQzNDUxMzY5MGFkaXF6a2N4 | Paper/PDF filed
Published 07 Sep 2024 06:05
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Preclinical development of novel ERRalpha inhibitors for treatment of Triple Negative Breast Cancer
1 Mar 2018 to 31 Aug 2021
Awaiting Public Project Summary
University of Ulster and Axis Bioservices Limited
1 Sep 2017 to 31 Aug 2020
To develop a system for 3D modelling and measurement of tumours grown on mice/rats via sophisticated image processing algorithms, increasing the accuracy and robustness of measurements; which has the potential to have significant commercial and social impact with global reach.